Introduction of magnetic and supermagnetic nanoparticles in new approach of targeting drug delivery and cancer therapy application.

Clicks: 506
ID: 84115
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #1 of 65 articles by views in drug metabolism reviews

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
In this article, the recent applications of different types of magnetic nanoparticles such as α-FeO (hematite), γ-FeO (maghemite), FeO (magnetite), hexagonal (MFeO), garnet (MFeO) and spinel (MFeO), where M represents one or more bivalent transition metals (Mn, Fe, Co, Ni, Ba, Sr, Cu, and Zn), and different materials for coating the surface of magnetic nanoparticles like poly lactic acid (PLA), doxorubicin hydrophobic (DOX-HCL), paclitaxel (PTX), EPPT-FITC, oleic acid, tannin, 3-Aminopropyltriethoxysilane (APTES), multi-wall carbon nanotubes (CNTs), polyethylenimine (PEI) and polyarabic acid in drug delivery, biomedicine and treatment of cancer, specially chemotherapy, are reviewed. MNPs possess large surface area to volume ratios because of their nano-size, low surface charge at physiological pH and they aggregate easily in solution due to their essential magnetic nature. These materials are widely used in biology and medicine in many cases. One targeted delivery technique that has gained prominence in recent years is the use of magnetic nanoparticles. In these systems, therapeutic compounds are attached to biocompatible magnetic nanoparticles and magnetic fields generated outside the body are focused on specific targets in vivo. The fields capture the particle complex, resulting in enhanced delivery to the target site. Also, the application of brand new supermagnetic nanoparticles, like Ba,SrFeO, is considered and studied in this paper.
Reference Key
avval2019introductiondrug Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Avval, Zhila Mohajeri;Malekpour, Leila;Raeisi, Farzad;Babapoor, Aziz;Mousavi, Seyyed Mojtaba;Hashemi, Seyyed Alireza;Salari, Marjan;
Journal drug metabolism reviews
Year 2019
DOI
10.1080/03602532.2019.1697282
URL
Keywords
cancer therapy drug delivery magnetic nanoparticles iron oxide supermagnetic

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.